Pulmatrix Receives $3,500,000 New Funding Round

  • Feed Type
  • Date
    2/22/2013
  • Company Name
    Pulmatrix
  • Mailing Address
    99 Hayden Avenue Lexington, MA 02421
  • Company Description
    Pulmatrix Inc. is a pharmaceutical company developing inhalable aerosols and enabling technologies that help control respiratory infectious disease and human-source airborne contamination.
  • Website
    http://www.pulmatrix.com
  • Transaction Type
    Debt
  • Transaction Amount
    $3,500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing-amended.
  • M&A Terms
  • Venture Investor
    Undisclosed